Cargando…

Advanced oxidation protein products induce apoptosis, and upregulate sclerostin and RANKL expression, in osteocytic MLO-Y4 cells via JNK/p38 MAPK activation

Advanced oxidation protein products (AOPPs) are recognized as novel markers of oxidative stress and contribute to various medical conditions, which are associated with secondary osteoporosis. However, little is currently known regarding the role of AOPPs in the development of secondary osteoporosis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Chaoqun, Huang, Dong, Wang, Kunyuan, Lin, Bochuan, Liu, Yuanhang, Liu, Songbo, Wu, Weichi, Zhang, Huiru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364877/ https://www.ncbi.nlm.nih.gov/pubmed/28000869 http://dx.doi.org/10.3892/mmr.2016.6047

Ejemplares similares

Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
por: Wijenayaka, Asiri R., et al.
Publicado: (2011)

Piezo1-mediated fluid shear stress promotes OPG and inhibits RANKL via NOTCH3 in MLO-Y4 osteocytes
por: Liu, Zhongcheng, et al.
Publicado: (2022)

Tumor necrosis factor-α antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis
por: Kim, Ji-Hye, et al.
Publicado: (2017)

The Osteocyte as a Novel Key Player in Understanding Periodontitis Through its Expression of RANKL and Sclerostin: a Review
por: de Vries, Teun J., et al.
Publicado: (2019)

The potential role of spectrin network in the mechanotransduction of MLO-Y4 osteocytes
por: Wu, Xin-Tong, et al.
Publicado: (2017)

Efficacy of Combined Therapy of Periosteum and Bone Allograft in a Critical-Sized Defect Model in New Zealand White Rabbits
por: Zhang, Dawei, et al.
Publicado: (2014)

Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover
por: Huybrechts, Yentl, et al.
Publicado: (2023)

Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy
por: Laster, Marciana, et al.
Publicado: (2023)

Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice
por: Liu, Wen, et al.
Publicado: (2019)

High Glucose Downregulates Connexin 43 Expression and Its Gap Junction and Hemichannel Function in Osteocyte-like MLO-Y4 Cells Through Activation of the p38MAPK/ERK Signal Pathway
por: Yang, Lei, et al.
Publicado: (2020)

Kindlin-2 mediates mechanotransduction in bone by regulating expression of Sclerostin in osteocytes
por: Qin, Lei, et al.
Publicado: (2021)

The Impact of the Extracellular Matrix Environment on Sost Expression by the MLO-Y4 Osteocyte Cell Line
por: Brady, Robert T., et al.
Publicado: (2022)

Focused Low-Intensity Pulsed Ultrasound (FLIPUS) Mitigates Apoptosis of MLO-Y4 Osteocyte-like Cells
por: Puts, Regina, et al.
Publicado: (2023)

IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
por: Jiang, Zengxin, et al.
Publicado: (2023)

Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes
por: Pacicca, Donna M., et al.
Publicado: (2019)

The crucial role of osteocyte-derived RANKL in bone homeostasis
por: Nakashima, Tomoki, et al.
Publicado: (2012)

Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin
por: Stegen, Steve, et al.
Publicado: (2018)

Effect of TNF-α-Induced Sclerostin on Osteocytes during Orthodontic Tooth Movement
por: Ohori, Fumitoshi, et al.
Publicado: (2019)

Identification of an intronic enhancer regulating RANKL expression in osteocytic cells
por: Yan, Minglu, et al.
Publicado: (2023)

Effect of High Static Magnetic Fields on Biological Activities and Iron Metabolism in MLO-Y4 Osteocyte-like Cells
por: Yang, Jiancheng, et al.
Publicado: (2021)

FOXO1 Mediates Advanced Glycation End Products Induced Mouse Osteocyte-Like MLO-Y4 Cell Apoptosis and Dysfunctions
por: Zhang, Citong, et al.
Publicado: (2019)

Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist
por: van Bezooijen, Rutger L., et al.
Publicado: (2004)

Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy
por: Toscani, Denise, et al.
Publicado: (2018)

Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo
por: Basha, Genc, et al.
Publicado: (2016)

Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence
por: Kim, Ha-Neui, et al.
Publicado: (2020)

Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways
por: Yang, Zhangshuo, et al.
Publicado: (2022)

Osteocyte Network; a Negative Regulatory System for Bone Mass Augmented by the Induction of Rankl in Osteoblasts and Sost in Osteocytes at Unloading
por: Moriishi, Takeshi, et al.
Publicado: (2012)

The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes
por: Siegenthaler, Barbara, et al.
Publicado: (2018)

Impact of FasL Stimulation on Sclerostin Expression and Osteogenic Profile in IDG-SW3 Osteocytes
por: Kratochvilova, Adela, et al.
Publicado: (2021)

S100A9 Increases IL-6 and RANKL Expressions through MAPKs and STAT3 Signaling Pathways in Osteocyte-Like Cells
por: Takagi, Ryosuke, et al.
Publicado: (2020)

Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma
por: Pua, Lesley Jia Wei, et al.
Publicado: (2022)

A conserved motif in JNK/p38-specific MAPK phosphatases as a determinant for JNK1 recognition and inactivation
por: Liu, Xin, et al.
Publicado: (2016)

Flumequine-Mediated Upregulation of p38 MAPK and JNK Results in Melanogenesis in B16F10 Cells and Zebrafish Larvae
por: Karunarathne, Wisurumuni Arachchilage Hasitha Maduranga, et al.
Publicado: (2019)

Functional and structural characterization of osteocytic MLO-Y4 cell proteins encoded by genes differentially expressed in response to mechanical signals in vitro
por: Meng, Fanchi, et al.
Publicado: (2018)

Tension force causes cell cycle arrest at G2/M phase in osteocyte-like cell line MLO-Y4
por: Shimizu, Natsuo, et al.
Publicado: (2023)

Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis
por: Kim, Hyung Joon, et al.
Publicado: (2019)

Osteocyte regulation of orthodontic force-mediated tooth movement via RANKL expression
por: Shoji-Matsunaga, Ayumi, et al.
Publicado: (2017)

TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation
por: Marahleh, Aseel, et al.
Publicado: (2019)

Effect of TNF-α on osteocyte RANKL expression during orthodontic tooth movement
por: Marahleh, Aseel, et al.
Publicado: (2021)

Connecting the Dots: Linking Osteocyte Activity and Therapeutic Modulation of Sclerostin by Extending a Multiscale Systems Model
por: Eudy, RJ, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ds4snrpm93af7qiec2jfsgglai